Successful treatment of cervical lymphadenitis caused by mycobacteria other than tuberculosis with rifabutin, clarithromycin, and protionamid;Rezidiv einer lymphadenitis colli durch atypische mykobakterien. Erfolgreiche therapie mit rifabutin, clarithromycin und protionamid

Monatsschrift fur Kinderheilkunde

Volumn 146, Issue 7, 1998, Pages 669-672

  Hebestreit, Alexandra ^a   Pistner, H ^a   Marx, A ^b   Schuster, V ^a   Bartels, H ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cervical lymphadenitis; Clarithromycin; Drug therapy; Non tuberculous mycobacteria (MOTT); Protionamid; Rifabutin

Indexed keywords

CLARITHROMYCIN; PROTIONAMIDE; RIFABUTIN;

ABSCESS; ANTIBIOTIC SENSITIVITY; ARTICLE; ATYPICAL MYCOBACTERIUM; CASE REPORT; CERVICAL LYMPH NODE; FEMALE; HUMAN; LYMPHADENITIS; PRESCHOOL CHILD; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0031879223     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001120050308     Document Type: Article

References (22)

1. American Thoracic Society (1987) Mycobacteriosis and the acquired immunodeficiency syndrome. Am Rev Respir Dis 136:492-496
2. Berger C, Pfyffer GE, Nadal D (1996) Treatment of nontuberculous mycobacterial lymphadenitis with clarithromycin plus rifabutin. J Pediatr 128:383-386
3. Clark JE, Magee JG, Cant AJ (1995) Non-tuberculous mycobacterial lymphadenopathy. Arch Dis Child 72:165-166
4. Cremer R, Dannecker G, Hoppe JE, Haber P, Niethammer D (1994) Nichttuberkulöse Mykobakterien als Ursache einer Lymphadenitis colli. Monatsschr Kinderheilkd 142:787-789
5. Ellner JJ, Goldberger MJ, Parenti DM (1991) Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution. J Infect Dis 163:1326-1335
6. Giacchino R, Tasso L, Losurdo G, Castagnola E, Olliaro P (1994) Safety of rifabutin in a three month old infant. Pediatr Infect Dis J 13:164
7. Grange JM, Yates MD, Pozniak A (1995) Bacteriologically confirmed non-tuberculous mycobacterial lymphadenitis in south east England: a recent increase in the number of cases. Arch Dis Child 72:516-517
8. Green PA, von Reyn FC, Smith RP (1993) Mycobacterium avium complex parotid Lymphadenitis: successful therapy with clarithromycin and ethambutol. Pediatr Infect Dis J 12:615-617
9. Horsburgh CR, Havlik JA, Ellis DA, Kennedy E, Fann SA, Dubois RE, Thompson SE (1991) Survival of patients with acquired immune deficiency syndrome and disseminated mycobacterium avium complex infection with and without antimycobacterial chemotherapy. Am Rev Respir Dis 144:557-559
10. Husson RN, Ross LA, Sandelli S, Inderlied CB, Venzon D, Lewis LL, Woods L, Conville PS, Witebsky FG, Pizzo PA (1994) Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children. J Pediatr 124:807-8014
11. Nightingale SD, Cameron DW, Gordin FM, Sullam PM, Cohn DL, Chaisson RE, Eron LJ, Sparti PD, Bihardi B, Kaufman DL, Stern JL, Pearce DD, Weinberg WG, LaMarca A, Siegal FP (1993) Two controlled trials of rifabutin prophylaxis against mycobacterium avium complex infection in AIDS. N Engl J Med 329 828-833
12. Rapp RP, Mc Craney SA, Goodman NL, Shaddick CJ (1994) New macrolide antibiotics: usefulness in infections caused by mycobacteria other than mycobacterium tuberculosis. Ann Pharmacother 28.1255-1263
13. Rathbun RC, Martin ES III, Eaton VE, Matthew EB (1991) Currrent and investigational therapies for AIDS-associated mycobacterium avium complex disease. Clin Pharmacol 10:280-291
14. Rastogi N, Bauriaud RM, Bourgoin A, Carbonelie B (1995) French multicenter study involving eight test sites for radiometric determination of activities of 10 antimicrobial agents against mycobacterium avium complex. Antimicrob Agents Chemother 39:538-644
15. Saitz EW (1981) Cervikal lymphadenitis caused by atypical mycobacteria. Pediatr Clin North Am 28 823-839
16. Schaad B, Votteler TP, Mc Cracken GH, Nelson JD (1979) Management of atypical lymphadenitis in childhood: a review based on 380 cases. J Pediatr 95:356-360
17. Schaad UB (1997) Nichttuberkulöse Mykobakteriosen. In Schaad UB (Hrsg) Padiatrische Infektiologie, 2. Aufl. Marseille, Munchen, S 349-350
18. Scholz H, Belohradsky BH, Kreth W, Roos R, Stehr K (1995) Tuberkulose und nichttuberkulöse mykobakterielle Krankheiten. In: Deutsche Gesellschaft fur padiatrische Infektiologie e.V. (DGPI) (Hrsg) DGPI Handbuch 1995, Infektionen bei Kindern und Jugendlichen. Futuramed, Munchen, S 485-496
19. Seydel JK, Schaper KJ, Rusch-Gerdes S (1992) Development of effective drug combinations for the inhibition of multiple resistant mycobacteria, especially of the mycobacterium avium complex. Chemotherapy 38:159-168
20. Shafran SD, Deschenes J, Miller M, Phillips P, Toma E (1994) Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC study group of the Canadian HIV trials network (Letter). N Engl J Med 330:438-439
21. Tessier MH, Amoric JC, Mechinaud F, Dubusset D, Litoux P, Stadler JF (1994) Clarithromycin for atypical mycobacterial lymphadenitis in non-immunocompromised children. Lancet 344:1778
22. Wolinsky E (1995) Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 20 954-963